By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Why Medical Device Regulatory Compliance is a Business Decision
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Health Reform > Why Medical Device Regulatory Compliance is a Business Decision
Health ReformNewsPublic Health

Why Medical Device Regulatory Compliance is a Business Decision

nealda
nealda
Share
3 Min Read
facebook
SHARE

 

The US Food and Drug Administration recently looked into complaints about a permanent birth control device called Essure. A medical team from Weill Cornell Medicine in New York reported a 10-fold higher occurrence of repeat operation during the first year of implantation. In Europe, the PIP breast implant remains an indelible scandal. The question here is why are approved devices causing serious safety concerns in the market? Clearly, tighter regulatory oversight does not prevent the rise of malfunctioning medical devices. On the part of the device manufacturer, following the regulations perfectly does not mean that all safety, quality and effectiveness parameters have been addressed.

Essure, sold by Bayer, was approved via the 510(k) process. This route exempts medical devices from clinical trials if they are proven to be substantially equivalent to a similarly marketed device. As a result, any clinical data obtained from abbreviated studies would be inadequate to give credible and representative conclusions about device safety and performance. Should Bayer have conducted a full randomised, blinded clinical investigation instead? The answer to this question should be derived from sensible business decision-making, and not a regulatory one. Fully understanding product characteristics from both benefit and risk perspectives is a vital underpinning of the value proposition for medical devices. The primary customers of medical devices are the end-users and/or patients whose requirements should rightfully take precedence above, beyond and despite regulatory rules.

A potent business tool specific to medical devices that could help to address this is the ISO14971 risk management standard. The requirements of this standard are the same for all medical devices regardless of risk classification and approval pathways. It requires all device manufacturers to take every reasonable step to ensure that risk levels are reduced as low as possible. Vis versa, shorter approval pathways for lower risk devices do not offer any relief to risk reduction measures. Therefore, if a thorough clinical trial is needed to provide a complete risk/benefit profile for a device, then this should be done despite the regulatory process. This means that a risk management process for a 510(k) approval should not be less thorough than for a PMA.

A device manufacturer that uses an abridged approval process as an excuse to cut corners on risk reduction will not only place a hazardous medical device in the market, but such indifference to basic total quality tenets is in itself ruinous to medical device innovation and long-term business competitiveness.

 

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

hospital bureaucracy
Health ReformHospital Administration

Don’t Let Paperwork Get in the Way of Your Work’s Purpose

September 25, 2013

Second Annual DEA Drug Take Back Day–Saturday April 30, 2011

April 28, 2011
what to do after a motorcycle accident and getting harassed
News

What to Do While Being Harassed After a Motorcycle Accident

October 9, 2021
obamacare
Health ReformPolicy & LawPublic Health

Tell Us Again Why We Need Young People

September 27, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?